ImmunityBio, Inc 10-Q for FY2025 Q2
ImmunityBio, Inc. (IBRX)
10-Q
2025-08-05
For: 2025-06-30
View Original
Added on
April 10, 2026
About this 10-Q
ImmunityBio, Inc filed this 10-Q on August 5, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).
Headline figures
Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $26.43M
- up 2423.9% from $1.05M a year earlier
- Net loss
- $92.56M
- compared with a net loss of $134.56M a year earlier
- Diluted EPS
- -$0.10
- compared with -$0.20 a year earlier